From Lab to Market: What South Africa's Health System Means for Your Diagnostic or Biotech Innovation | H3 Health Hub & German Accelerator

What: Informational seminar

When: Wednesday, September 30 | 1:30 - 2:30 PM

Where: Zoom

Info: South Africa runs one of Africa's most developed health systems: a genuine two-tier market and real regulatory clarity. Most German diagnostic, digital health and biotech teams have never had someone map out what that actually means for them.

This free seminar will be led by Dr Charlotte Maserumule (Market Access Africa), a Cambridge PhD who took her own diagnostics from lab to a WHO prequalification submission. 

She'll cover:
🧬 What South Africa's disease landscape and population diversity mean for clinical validation
🏥 How the two-tier health system actually decides: who pays, who procures, public vs private
📋 The regulatory and validation pathway from research prototype to product
🚀 What this means concretely for a lab-stage or early spin-out team weighing a South Africa hypothesis
 

The seminar will also preview the German Accelerator Market Discovery LifeScience program, for founders who want to go deeper with hospitals, payers and regulators on the ground afterward.

Sign up here:dkfz-de.zoom-x.de/meeting/register/FJtBpPirQXWkG5m1RBitXA